BioAge Labs, Inc.

Historical 13F Holders

Symbol
BIOA
CUSIP
09077V100
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 09077V100 since 12/18/2024, newest first.

Filer % of Class Filed
Cormorant Asset Management, LP 13G/A Amendment 4
5.4% 8/14/2026
Event 6/30/2026
Khosla Ventures VI, L.P. 13G/A Amendment 1
4.0% 5/15/2026
Event 5/15/2026
Cormorant Asset Management, LP 13G/A Amendment 3
6.5% 5/15/2026
Event 3/31/2026
BlackRock, Inc. 13G 5.0% 4/27/2026
Event 3/31/2026
Cormorant Asset Management, LP 13G/A Amendment 2
5.7% 2/17/2026
Event 12/31/2025
ADAR1 Capital Management, LLC 13G/A Amendment 1
0.4% 2/17/2026
Event 12/31/2025
Kristen Fortney 13G/A Amendment 1 7.2% 2/13/2026
Event 12/31/2025
Cormorant Asset Management, LP 13G/A Amendment 1
6.0% 8/14/2025
Event 6/30/2025
ADAR1 Capital Management, LLC 13G
5.4% 8/14/2025
Event 6/30/2025
RA Capital Management, L.P. 13G/A Amendment 1
3.7% 2/14/2025
Event 12/31/2024
Cormorant Asset Management, LP 13G
7.3% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 2 313 $2.22 k
2026 Q2 163 37.7 M $925 M
2026 Q1 152 34.7 M $606 M
2025 Q4 119 23.7 M $315 M
2025 Q3 101 21.4 M $126 M
2025 Q2 88 20.8 M $86.0 M
2025 Q1 69 20.3 M $76.2 M
2024 Q4 66 19.6 M $114 M
2024 Q3 60 20.9 M $435 M